Goldman Sachs
RDHL

Goldman Sachs’s Redhill Biopharma RDHL Stock Holding History

Goldman Sachs’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18
Closed -$2.51K – 6172
2022
Q4 		$2.51K Sell
18
-21
-54% -$9.1K ﹤0.01% 5860
2022
Q3 		$20K Buy
39
+3
+8% +$2.61K ﹤0.01% 5937
2022
Q2 		$32K Sell
36
-1
-3% -$1.37K ﹤0.01% 6112
2022
Q1 		$93K Sell
37
-7
-16% -$16.6K ﹤0.01% 6128
2021
Q4 		$114K Sell
44
-32
-42% -$128K ﹤0.01% 6096
2021
Q3 		$350K Buy
76
+20
+36% +$136K ﹤0.01% 5406
2021
Q2 		$385K Sell
56
-3
-5% -$20.7K ﹤0.01% 5365
2021
Q1 		$428K Sell
59
-59
-50% -$495K ﹤0.01% 5231
2020
Q4 		$950K Sell
118
-5
-4% -$44.9K ﹤0.01% 4226
2020
Q3 		$1.26M Buy
123
+71
+137% +$582K ﹤0.01% 3915
2020
Q2 		$346K Buy
52
+34
+189% +$234K ﹤0.01% 4560
2020
Q1 		$82K Buy
+18
New +$90.1K ﹤0.01% 4974
2015
Q2 		– Sell
-29
Closed -$422K – 7404
2015
Q1 		$422K Hold
29
– – ﹤0.01% 5311
2014
Q4 		$387K Hold
29
– – ﹤0.01% 5528
2014
Q3 		$382K Hold
29
– – ﹤0.01% 5520
2014
Q2 		$507K Hold
29
– – ﹤0.01% 5302
2014
Q1 		$409K Hold
29
– – ﹤0.01% 5461
2013
Q4 		$342K Hold
29
– – ﹤0.01% 5592
2013
Q3 		$311K Hold
29
– – ﹤0.01% 5540
2013
Q2 		$278K Buy
+29
New +$310K ﹤0.01% 5369

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Goldman Sachs's RDHL Position: Q1 2023 in Review

Goldman Sachs sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 18 shares — an estimated $2.51K sold.

Goldman Sachs first reported a position in RDHL in Q2 2013 and held it in 20 quarters. The position peaked at $1.26M in Q3 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Goldman Sachs reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 18 Redhill Biopharma shares in Q1 2023, an estimated $2.51K.
  • Goldman Sachs first reported a position in Redhill Biopharma in Q2 2013 and held it in 20 quarters.
  • Goldman Sachs's Redhill Biopharma position peaked at $1.26M in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.